Loading…
Loading…
Base rate computed from analyst-asserted responds_to: edges in the reverse direction (target-country → issuer-country) for prior issuer-actions on the same target. Modal type + lag percentiles only — not a model output. Treat as a historical anchor for sizing counter-response scenarios, not a forecast in itself.
The first US outbound-investment screening regime — analogous in spirit to inbound CFIUS but inverted (screening US capital flowing OUT to a foreign jurisdiction).
Three-tier structure:
1. Prohibited transactions. US persons are barred from making investments in PRC entities engaged in the most sensitive activities — e.g. designing or producing advanced AI chips above set capability thresholds, certain quantum computing applications, AI systems for weaponisation or mass surveillance.
2. Notifiable transactions. Less sensitive but still- covered transactions require post-closing notification to Treasury within 30 days. This includes investments in Chinese semiconductor / AI / quantum entities below the prohibition threshold but within the covered scope.
3. Excepted transactions. Investments in publicly-traded securities of a covered Chinese entity (passive market-cap exposure), index funds with diversified holdings, and debt-financing arrangements meeting specific criteria are excepted. This carve-out is broad: most retail-investor exposure to Chinese tech via ETFs is unaffected.
Compliance burden falls on US persons (US citizens, lawful permanent residents, and US-organized entities including their controlled foreign branches). Penalties under IEEPA can include civil fines up to $250k per violation or twice the transaction value, plus criminal exposure for willful violations.
scaffolding for outbound capital screening that EU member states (the Netherlands, Germany, France) and the UK had been considering for years. Several EU jurisdictions are now drafting their own analogues.
prohibited transactions is narrow — but the compliance- uncertainty cost meaningfully reduced US VC + PE willingness to participate in Chinese AI / chip rounds even before the rule went effective. Sequoia, GGV Capital, GSR Ventures restructured / spun off China operations in 2023-2024 partly in response.
out keeps mass-market investor exposure unaffected; (b) primary US VC / PE flows to covered Chinese entities had already declined ~70% YoY 2022→2023 before the rule was finalised, suggesting market behaviour was already pricing in the regime.
fund GPs to certify compliance with the outbound regime, effectively foreclosing diligence on covered Chinese rounds.
(PIF, Mubadala, ADIA), Gulf VC arms, Asian regional funds partly substituted for departing US capital in 2024-2025.
BIS export controls (filed: 2022-10-07-us-bis-advanced-ai-chip-controls-china, 2023-10-17-us-bis-advanced-chip-controls-expansion). Goods controls + capital controls + manufacturing subsidies (CHIPS Act, IRA) form the three pillars of the US tech-decoupling industrial-policy stack.
(charter §9 #18, pending IPTM filing) was modelled on EO 14105.
issued under Biden but takes effect under Trump. Treasury enforcement priorities + exclusion-grant rates over 2025 will determine the regime's practical bite.
further "national security technologies" via amendment. Biotech, advanced materials, and clean-energy critical inputs have been mentioned by Treasury officials as candidates.
enforcement actions begin landing — the 2 Jan 2025 effective date is the meaningful trigger, not the EO itself.